Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells.

about

Methylation of DNA and chromatin as a mechanism of oncogenesis and therapeutic target in neuroblastoma.Correlation of CT signs with lymphatic metastasis and pathology of neuroblastoma in children.

P2860

Q55267254-4096A4D5-F9A1-4296-890B-79F4B66DBD82 Q55709533-7AA05800-9AEC-4A68-956D-FE5560A2BF0B

P2860

Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells.

Item

http://www.wikidata.org/entity/Q51334063

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Combined Treatments with a Ret ...... in Human Neuroblastoma Cells.

@en

Combined Treatments with a Ret ...... in Human Neuroblastoma Cells.

@nl

type

Item

label

Combined Treatments with a Ret ...... in Human Neuroblastoma Cells.

@en

Combined Treatments with a Ret ...... in Human Neuroblastoma Cells.

@nl

prefLabel

Combined Treatments with a Ret ...... in Human Neuroblastoma Cells.

@en

Combined Treatments with a Ret ...... in Human Neuroblastoma Cells.

@nl

P1476

Combined Treatments with a Ret ...... in Human Neuroblastoma Cells.

@en

P2093

Algemir Lunardi Brunetto

http://www.w3.org/2001/XMLSchema#string

Ana Lucia Abujamra

http://www.w3.org/2001/XMLSchema#string

André Tesainer Brunetto

http://www.w3.org/2001/XMLSchema#string

Caroline Brunetto de Farias

http://www.w3.org/2001/XMLSchema#string

Fábio Klamt

http://www.w3.org/2001/XMLSchema#string

Igor Araujo Vieira

http://www.w3.org/2001/XMLSchema#string

Lauro J Gregianin

http://www.w3.org/2001/XMLSchema#string

Marienela Buendia

http://www.w3.org/2001/XMLSchema#string

Patrícia Luciana da Costa Lopez

http://www.w3.org/2001/XMLSchema#string

Viviane Rösner Almeida

http://www.w3.org/2001/XMLSchema#string

P2860

Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation

Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study

Retinoids induce stem cell differentiation via epigenetic changes

A role for distinct cell types in determining malignancy in human neuroblastoma cell lines and tumors.

Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation.

The "neuro" of neuroblastoma: Neuroblastoma as a neurodevelopmental disorder.

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.

Retinoic acid and histone deacetylases regulate epigenetic changes in embryonic stem cells

Neuroblastoma: biological insights into a clinical enigma.

Stem cells and cancer; the polycomb connection.

P2888

s12035-016-0250-3

P304

7610-7619

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12035-016-0250-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

R Roesler

P577

2016-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27832522

http://www.w3.org/2001/XMLSchema#string

Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells.

about

P2860

P2860

Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698